Can testosterone replacement therapy correct and prevent anemia?

Testosterone replacement therapy (TRT) has been studied for its effect on haemoglobin levels in men with clinically confirmed hypogonadism. In this episode, we explain how testosterone influences red blood cell production and when treatment may be considered in Europe.

In this episode, we cover:

• What anemia is (low haemoglobin or reduced oxygen-carrying capacity)

• Common causes of anemia in adults

• How testosterone stimulates erythropoiesis (red blood cell production)

• Evidence linking TRT to increased haemoglobin levels

• The risk of excessive red blood cell elevation (polycythaemia)

• Required blood tests before and during TRT

• When anemia requires further investigation for underlying causes

• Situations where prescription requests may be declined

Doctors assess testosterone levels with confirmed laboratory testing, full blood count results, iron status, kidney function, and underlying health conditions before considering therapy. Testosterone is not appropriate for unexplained anemia without confirmed hormone deficiency. Some patients require in-person evaluation or referral for further diagnostic work-up.

This episode reflects how hormone therapy and blood disorders are reviewed within structured medical assessment in European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/testosterone-replacement-therapy-can-correct-and-prevent-anemia